BioBridge Global Introduces BBG Advanced Therapies: New Subsidiary to Support the Development of Cell and Gene Therapies

Board of Directors

Gabriele G. Niederauer, PhD

Chair

Steven R. Brook, JD

Immediate Past Chair

Michael Kreager, JD

Chair Emeritus, Assistant Secretary​

Randi Brosterman Hutchens

Vice-Chair

James Rosenblatt, JD

Secretary

Jeannie Frazier

Treasurer

Martin J. Landon

CEO, BioBridge Global

J. Charlene Davis, PhD

Maj. Gen. (Ret.) Barbara R. Holcomb, RN, BSN, MSN​

Donald H. Jenkins, MD, FACS​

Charles J. Lerner, MD, FACP, FSHEA​

Al Rajwani

Jenna Saucedo-Herrera​

Michael D. Beldon (Director Emeritus)​

John Feik (Director Emeritus)​

Kenneth (Kenny) Gindy, JD (Director Emeritus)​

Kenneth P. Trevett, JD (DIrector Emeritus)​